Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF)

NCT02943785 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1426

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Edoxaban-based Regimen
DRUG: VKA-based Regimen

Sponsor

Daiichi Sankyo

Collaborators

[object Object]